Business Standard

UK to infect volunteers with coronavirus in trials for early vaccine

Britain signed a contract with Open Orphan Plc and its London-based unit, hVivo, that paves the way for human challenge trials, the company said on Tuesday

Vaccine, Covid
Premium

The tests, backed by 33.6 million pounds ($43 million) in government funding, would be carried out at the Royal Free Hospital’s specialist research unit in London

James Paton | Bloomberg
The first trials to deliberately infect people with the coronavirus to accelerate the development of vaccines could occur in the UK next year as part of an agreement reached by the government.

Britain signed a contract with Open Orphan Plc and its London-based unit, hVivo, that paves the way for human challenge trials, the company said on Tuesday. The plan is to manufacture the virus and conduct a study to determine how much of the pathogen to expose volunteers to in the trials.

The tests, backed by 33.6 million pounds ($43 million) in government funding, would be carried out at the Royal

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 21 2020 | 1:31 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com